Patents by Inventor Ning-Yi Li

Ning-Yi Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cancer specific gene MH15
    Patent number: 7507532
    Abstract: MH15 (Hn1L) is identified as an oncogene. Methods and compositions for detecting and diagnosing cancer in patients are provided, by determining the level of MH15 expression in biological samples. Also provided are methods for screening for inhibitors and moderators of MH15 expression and activity, as well as compositions comprising compounds and molecules that inhibit or moderate MH15 expression or activity, thereby treating cancer, in vivo.
    Type: Grant
    Filed: March 7, 2005
    Date of Patent: March 24, 2009
    Assignee: Medigen Biotechnology Corporation
    Inventors: Stanley Chang, Hsun-Lang Chang, Wei-Ying Kuo, Kuo-Yen Chen, Ning-Yi Li, Chih-Ping Hsu, Pei-Hsun Ho
  • Cancer specific gene MH15
    Publication number: 20060068411
    Abstract: MH15 (Hn1L) is identified as an oncogene. Methods and compositions for detecting and diagnosing cancer in patients are provided, by determining the level of MH15 expression in biological samples. Also provided are methods for screening for inhibitors and moderators of MH15 expression and activity, as well as compositions comprising compounds and molecules that inhibit or moderate MH15 expression or activity, thereby treating cancer, in vivo.
    Type: Application
    Filed: March 7, 2005
    Publication date: March 30, 2006
    Applicant: Medigen Biotechnology Corporation
    Inventors: Stanley Chang, Hsun-Lang Chang, Wei-Ying Kuo, Kuo-Yen Chen, Ning-Yi Li, Chih-Ping Hsu, Pei-Hsun Ho
  • Cancer specific gene MG20
    Publication number: 20050153352
    Abstract: MG20 (CCNDBP1) is identified as an oncogene. Methods and compositions for detecting and diagnosing cancer in patients are provided, by determining the level of MG20 expression in biological samples. Also provided are methods for screening for inhibitors and moderators of MG20 expression and activity, as well as compositions comprising compounds and molecules that inhibit or moderate MG20 expression or activity, thereby treating cancer, in vivo.
    Type: Application
    Filed: January 7, 2005
    Publication date: July 14, 2005
    Inventors: Stanley Chang, Hsun-Lang Chang, Wei-Ying Kuo, Kuo-Yen Chen, Ning-Yi Li